AMNEAL PHARMACEUTICALS, INC. Increase (Decrease) in Due from Related Parties
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Increase (Decrease) in Due from Related Parties of -$25.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in due from related parties for the quarter ending 2026-06-30 was -$81.00K, a 107.32% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in due from related parties for the quarter ending 2026-03-31 was $56.00K, a 2700.00% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in due from related parties for the quarter ending 2025-12-31 was -$817.00K.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in due from related parties for the quarter ending 2025-09-30 was -$278.00K.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in due from related parties for fiscal 2025 was $13.00K.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in due from related parties for fiscal 2024 was -$482.00K, a 198.37% decline from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in due from related parties for fiscal 2023 was $490.00K.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in due from related parties for fiscal 2022 was -$646.00K.
| Period end | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 9 month | Increase (Decrease) in Due from Related Parties 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$25.00K 10-Q · filed 2026-08-06 | -$842.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $56.00K 10-Q · filed 2026-05-07 | -$761.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.04M derived: sum of 3 quarters · filed 2026-05-07 | $67.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.09M derived: sum of 2 quarters · filed 2026-02-27 | $11.00K derived: sum of 3 quarters · filed 2026-08-06 | $13.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | -$278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $828.00K derived: sum of 2 quarters · filed 2026-08-06 | $830.00K 10-Q · filed 2025-11-06 | -$135.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.11M 10-Q · filed 2026-08-06 | $143.00K derived: sum of 3 quarters · filed 2026-08-06 | -$2.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-07 | -$963.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.11M derived: sum of 3 quarters · filed 2026-05-07 | -$1.04M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$965.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.11M derived: sum of 2 quarters · filed 2026-02-27 | -$1.04M derived: sum of 3 quarters · filed 2026-02-27 | -$482.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | -$145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$79.00K derived: sum of 2 quarters · filed 2025-11-06 | $483.00K 10-Q · filed 2025-11-06 | -$158.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $628.00K 10-Q · filed 2025-08-07 | -$13.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.47M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $562.00K 10-Q · filed 2025-05-07 | -$79.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.40M derived: sum of 3 quarters · filed 2026-02-27 | $1.52M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$641.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $841.00K derived: sum of 2 quarters · filed 2026-02-27 | $960.00K derived: sum of 3 quarters · filed 2026-02-27 | $490.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.60M derived: sum of 2 quarters · filed 2024-11-12 | $1.13M 10-Q · filed 2024-11-12 | -$32.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$351.00K 10-Q · filed 2024-08-09 | -$1.51M derived: sum of 3 quarters · filed 2025-02-28 | -$1.16M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$470.00K 10-Q · filed 2024-05-08 | -$1.63M derived: sum of 2 quarters · filed 2025-02-28 | -$1.27M derived: sum of 3 quarters · filed 2025-02-28 | -$1.11M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$805.00K derived: sum of 2 quarters · filed 2025-02-28 | -$642.00K derived: sum of 3 quarters · filed 2025-02-28 | -$646.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $521.00K derived: sum of 2 quarters · filed 2023-11-09 | $517.00K 10-Q · filed 2023-11-09 | $407.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $159.00K 10-Q · filed 2023-08-08 | $49.00K derived: sum of 3 quarters · filed 2024-03-14 | $231.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$4.00K 10-Q · filed 2023-05-09 | -$114.00K derived: sum of 2 quarters · filed 2024-03-14 | $68.00K derived: sum of 3 quarters · filed 2024-03-14 | -$7.01M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $72.00K derived: sum of 2 quarters · filed 2024-03-14 | -$7.01M derived: sum of 3 quarters · filed 2024-03-14 | -$7.31M 10-K · filed 2024-03-14 |
| 2021-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$6.90M derived: sum of 2 quarters · filed 2022-11-07 | -$7.20M 10-Q · filed 2022-11-07 | -$6.74M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | -$7.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$7.38M 10-Q · filed 2022-08-08 | -$6.92M derived: sum of 3 quarters · filed 2023-03-03 | -$7.16M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-03-31 | -$301.00K 10-Q · filed 2022-05-06 | $157.00K derived: sum of 2 quarters · filed 2023-03-03 | -$80.00K derived: sum of 3 quarters · filed 2023-03-03 | -$637.00K derived: sum of 4 quarters · filed 2023-03-03 |
| 2020-12-31 | $458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $221.00K derived: sum of 2 quarters · filed 2023-03-03 | -$336.00K derived: sum of 3 quarters · filed 2023-03-03 | -$412.00K 10-K · filed 2023-03-03 |
| 2020-09-30 | -$237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$794.00K derived: sum of 2 quarters · filed 2021-11-08 | -$870.00K 10-Q · filed 2021-11-08 | -$1.24M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$557.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$633.00K 10-Q · filed 2021-08-09 | -$999.00K derived: sum of 3 quarters · filed 2022-03-01 | -$1.32M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$76.00K 10-Q · filed 2021-05-07 | -$442.00K derived: sum of 2 quarters · filed 2022-03-01 | -$761.00K derived: sum of 3 quarters · filed 2022-03-01 | $549.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$685.00K derived: sum of 2 quarters · filed 2022-03-01 | $625.00K derived: sum of 3 quarters · filed 2022-03-01 | $939.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $991.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.30M 10-Q · filed 2020-11-06 | $1.21M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.62M 10-Q · filed 2020-08-06 | $1.52M derived: sum of 3 quarters · filed 2021-03-01 | $1.71M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $314.00K 10-Q · filed 2020-05-11 | $214.00K derived: sum of 2 quarters · filed 2021-03-01 | $403.00K derived: sum of 3 quarters · filed 2021-03-01 | -$5.40M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $89.00K derived: sum of 2 quarters · filed 2021-03-01 | -$5.71M derived: sum of 3 quarters · filed 2021-03-01 | -$10.93M 10-K · filed 2021-03-01 |
| 2018-09-30 | $189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$5.61M derived: sum of 2 quarters · filed 2019-11-07 | -$10.83M 10-Q · filed 2019-11-07 | -$3.95M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$11.02M 10-Q · filed 2019-08-05 | -$4.13M derived: sum of 3 quarters · filed 2020-03-02 | -$1.95M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$5.21M 10-Q · filed 2019-05-09 | $1.67M derived: sum of 2 quarters · filed 2020-03-02 | $3.85M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $9.07M derived: sum of 2 quarters · filed 2020-03-02 | $5.49M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$1.40M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$3.58M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | -$307.00K 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |